ClinicalTrials.Veeva

Menu

Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women

U

Universitaire Ziekenhuizen KU Leuven

Status

Unknown

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02209129
B322201421047

Details and patient eligibility

About

Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both breasts in two views in order to investigate the additional value of tomosynthesis in the diagnosis of breast cancer.

Enrollment

1,000 estimated patients

Sex

Female

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women
  • more than 17% risk for breast cancer (IBIS calculation)
  • > 40y old

Exclusion criteria

  • < 40y old

Trial design

1,000 participants in 1 patient group

women at high risk for breast cancer

Trial contacts and locations

1

Loading...

Central trial contact

Hilde Vandenhoutte; Chantal Van Ongeval, MD, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems